Pfizer Gives Gov't More Time To Study $2.3B Trillium Deal
By Christopher Cole ( October 13, 2021, 3:09 PM EDT) -- Pfizer Inc. has voluntarily provided the Federal Trade Commission an extra 30 days to review its planned $2.3 billion takeover of blood cancer drugmaker Trillium Therapeutics Inc. for antitrust issues....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.